Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. (LFCR) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · LFCR · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
10
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Lifecore Biomedical, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
LFCR insider buying and selling by quarter
LFCR insider selling · LFCR insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · LFCR ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
LFCR executive sell shares · LFCR board member insider trading · LFCR insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | OBUS NELSON Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Aryeh Jason Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Schechter Joshua Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Korenberg Matthew E Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Antunes Humberto Calheiros Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | Johnson Paul Harold Director | Award | 25,907 | — | Form 4 |
| Jun 4, 2026 | HOUDE LOVAS KATRINA Director | Award | 25,907 | — | Form 4 |
| May 20, 2026 | Josephs Paul CEO · Director | Other | 40,413 | $185K | Form 4 |
| Apr 14, 2026 | Salus Thomas D. Chief Legal & Administration | Other | 24,645 | $128K | Form 4 |
| Mar 2, 2026 | Salus Thomas D. Chief Legal & Administration | Award | 30,000 | — | Form 4 |
| Sep 3, 2025 | Lake Ryan David CFO | Other | 22,932 | $177K | Form 4 |
| Jul 15, 2025 | OBUS NELSON Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Kiper Christopher S Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Johnson Paul Harold Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Aryeh Jason Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Korenberg Matthew E Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Antunes Humberto Calheiros Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | Schechter Joshua Director | Award | 19,506 | — | Form 4 |
| Jul 15, 2025 | HOUDE LOVAS KATRINA Director | Award | 19,506 | — | Form 4 |
| Jul 8, 2025 | Salus Thomas D. Chief Legal & Administration | Option | 37,000 | — | Form 4 |
| Jul 8, 2025 | Salus Thomas D. Chief Legal & Administration | Other | 11,022 | $90K | Form 4 |
| Jul 8, 2025 | Lake Ryan David CFO | Option | 75,000 | — | Form 4 |
| Jul 8, 2025 | Lake Ryan David CFO | Other | 32,806 | $269K | Form 4 |
| Jul 8, 2025 | Josephs Paul CEO · Director | Option | 150,000 | — | Form 4 |
| Jul 8, 2025 | Josephs Paul CEO · Director | Other | 54,857 | $449K | Form 4 |
Salus Thomas D.
Chief Legal & Administration
Date
Apr 14
Shares
24,645
Price
$5.20
Value
$128K
Salus Thomas D.
Chief Legal & Administration
Date
Mar 2
Shares
30,000
Price
—
Value
—
Salus Thomas D.
Chief Legal & Administration
Date
Jul 8
Shares
37,000
Price
—
Value
—
Salus Thomas D.
Chief Legal & Administration
Date
Jul 8
Shares
11,022
Price
$8.19
Value
$90K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About LFCR insider trading
LFCR insider trades
Lifecore Biomedical, Inc. (LFCR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Salus Thomas D. (Chief Legal & Administration), Josephs Paul (CEO · Director), Lake Ryan David (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. LFCR insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Lifecore Biomedical, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
LFCR insider trading · 5 questionsThe insiders of Lifecore Biomedical, Inc. (LFCR) include executives and directors such as Salus Thomas D. (Chief Legal & Administration), Josephs Paul (CEO · Director), Lake Ryan David (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026